Cohort Company News - MedTech Innovator

Avenda Health’s Male ‘Lumpectomy’ Receives Breakthrough Device Designation

DateMay 13 2021

Avenda Health has been awarded Breakthrough Device Designation for a male “lumpectomy” product in development designed to treat prostate cancer in-office while preserving quality of life.

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

DateMay 13 2021

PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around the world.

Bigfoot Scores FDA Clearance for Diabetes Management System

DateMay 12 2021

Bigfoot Biomedical is a company that MD+DI readers should be quite familiar with by now. In 2017, the diabetes company was selected as the readers' choice for Medtech Company of the Year. The company is developing products to optimize insulin dosing and provide automated insulin delivery for people with insulin-requiring diabetes.

Mindera Raises Over $12M Series A-2 Financing

DateMay 12 2021

Mindera Corporation today announced a $12.6M Series A-2 capital raise. The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development.

Nanowear announces commercial distribution partnership in A.I.-based post-surgical recovery monitoring

DateMay 11 2021

Nanowear www.nanowearinc.com, the leading nanotechnology and A.I.-based remote diagnostic company, today announced a commercial distribution partnership with a world leading aesthetic and reconstructive surgical device-manufacturer, to enhance and optimize post-surgical recovery for both patients and surgeons.

FineHeart Breaks New Ground With Successful Removal of the ICOMS FLOWMAKER® in a 90-day In-vivo Trial

DateMay 04 2021

FineHeart S.A a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the successful, simple, and breakthrough implantation and removal of its device in a 90-day in-vivo trial.

Bone Health Technologies Closes $2.5M

DateMay 03 2021

Bone Health Technologies has closed a $2.5 million funding round and appointed three members to its Board of DIrectors: Karen Drexler; Nancy Lynch, M.D.; and Sam Goldberger, M.D.

Soundbite Medical Solutions Announces FDA Approval for SoundBite® Crossing System – Peripheral (14P)

DateApr 22 2021

Soundbite announces FDA 510(k) Approval for SoundBite® Crossing System - Peripheral (SCS-P) with the 0.014” Active Wire (14P).

PyrAmes Raises $6 Million in Series A Financing

DateApr 20 2021

PyrAmes, Inc., a digital healthcare company focused on innovative products for continuous blood pressure monitoring, today announced the completion of a $6 million Series A financing.

Moving Analytics Raises $6M to Increase Virtual Cardiac Rehab Solutions and Expand Team Amidst Telehealth Industry Growth

DateApr 19 2021

Moving Analytics, a telehealth company providing virtual cardiac rehab solutions, today announced it raised $6M in a Series Seed-2 round.

Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development

DateApr 15 2021

Medable Inc. today announced $78 million in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry's shift to patient-centered drug development.

2Morrow Raises $1.5M to Increase Access to Evidence-Based Digital Health

DateApr 14 2021

2Morrow, Inc., a leader in offering evidence-based, digital health platforms, announces a $1.5M investment led by Seattle area life science investor WRF Capital.

Moray Medical Boosts Seed Funding to $5.7 Million

DateApr 12 2021

Robotics startup Moray Medical announced it has closed a total of $5.7 million in seed funding, an increase of $2.4 million compared to the initial raise reported in January.

Singapore creates Magnesium-based bioresorbable implant technology for surgeries, featuring Magloy Tech

DateApr 08 2021

SRS Life Sciences, a global company headquartered in Singapore focused on lessening disease burden across emerging nations, and Magloy Tech, a spin-off from the National University of Singapore’s Graduate Research Innovation Programme (GRIP), have joined forces to internationally further develop and commercialise bioresorbable magnesium implants for orthopaedics and trauma surgery.

FDA Grants Donisi De Novo Clearance for Innovative Contact-Free Multiparameter Health Sensing Solution

DateApr 08 2021

The U.S. Food and Drug Administration (FDA) has granted Donisi's revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market.

Explorer Surgical raises nearly $2.6M

DateApr 07 2021

Explorer Surgical has raised nearly $2.6 million as it brings on medtech company customers looking to communicate with surgeons remotely.

Empirical Spine’s LimiFlex Device Granted Breakthrough Designation Status

DateApr 06 2021

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device status to Empirical Spine Inc.'s LimiFlex Paraspinous Tension Band.

Sentien Biotechnologies Completes Enrollment of First Cohort in Phase 1/2 Trial of Ex Vivo MSC Therapy for the Treatment of Severe COVID-19

DateMar 30 2021

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced it has completed enrollment of the first cohort in its Phase 1/2 study of SBI-101 for the treatment of severe COVID-19. SBI-101, Sentien’s innovative cell-based therapy, is being evaluated in COVID-19 patients suffering from both acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) requiring renal replacement therapy (RRT).

Augmedics, Augmented Reality Surgical Image Guidance Pioneer, Raises $36 Million in Series C Fundraising

DateMar 30 2021

Augmedics, a pioneer in augmented reality surgical image guidance, announced today that it has raised $36 million in an over-subscribed Series C financing with an international syndicate of Israel-US investors.

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

DateMar 30 2021

PolyVascular Hires Will Clifton, MD, as COO to Manage Path to Human Trials in US; Ultimate Goal to Help 1 Million Pediatric Patients With Congenital Heart Disease Around the World With More Dependable and Affordable Solution.